|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Total net revenues | |||||
| Cost of revenues (exclusive of amortization of intangible assets included below) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of intangible assets | |||||
| Restructuring and impairment expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Interest income (expense) | |||||
| Gain from change in fair value of warrants | |||||
| Dividend income | |||||
| (Loss) Gain from change in fair value of earnout liabilities | |||||
| Other income, net | |||||
| Total other income (expense), net | |||||
| INCOME (LOSS) BEFORE INCOME TAXES | |||||
| Loss before income taxes | |||||
| Income tax provision (benefit) | |||||
| Equity method investment (loss) gain | |||||
| Net loss | |||||
| LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS | |||||
| NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS | |||||
| Net loss per common share | |||||
| Basic loss per share attributable to common stockholders (in dollars per share) | |||||
| Diluted loss per share attributable to common stockholders (in dollars per share) | |||||
| Weighted average common shares used in net loss per share attributable to common shareholders | |||||
| Basic common shares (in shares) | |||||
| Diluted common shares (in shares) | |||||
Loading...